{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:19:19Z","timestamp":1789514359411,"version":"build-2803163510"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12954-016-0105-2","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T14:57:56Z","timestamp":1461077876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A scoping review of home-produced heroin and amphetamine-type stimulant substitutes: implications for prevention, treatment, and policy"],"prefix":"10.1186","volume":"13","author":[{"given":"Evelyn","family":"Hearne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul Cornelius","family":"Grund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Claire","family":"Van Hout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"105_CR1","first-page":"173","volume-title":"Interventions for amphetamine misuse","author":"JPC Grund","year":"2009","unstructured":"Grund JPC, Z\u00e1bransk\u00fd T, Irwin K, Heimer R. Stimulant use in Central and Eastern Europe: how recent social history shaped current drug consumption patterns. In: Pates R, Riley D, editors. Interventions for amphetamine misuse. Oxford: Wiley-Blackwell; 2009. p. 173\u2013204."},{"key":"105_CR2","first-page":"41","volume-title":"HIV and AIDS: A global view","author":"JPC Grund","year":"2002","unstructured":"Grund JPC. A Candle lit from both sides: the epidemic of HIV infection in Central and Eastern Europe. In: McElrath K, editor. HIV and AIDS: A global view. Westport, CT: Greenwood Press; 2002. p. 41\u201368."},{"key":"105_CR3","volume-title":"HIV\/AIDS in Russia and Eurasia. Volume 2","author":"R Heimer","year":"2007","unstructured":"Heimer R, Booth RE, Irwin KS, Merson MH. HIV and drug use in Eurasia. In: Twigg JL, editor. HIV\/AIDS in Russia and Eurasia. Volume 2. Basingstoke, Hampshire, UK: Palgrave Macmillan; 2007."},{"issue":"Suppl. 1","key":"105_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2753\/PPC1075-8216560103","volume":"56","author":"AV Orlova","year":"2009","unstructured":"Orlova AV. The Russian \u201cwar on drugs\u201d: a kinder, gentler approach? Probl Post Communism. 2009;56 Suppl 1:23\u201334.","journal-title":"Probl Post Communism"},{"issue":"Suppl. 4","key":"105_CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/002204269902900402","volume":"29","author":"KL Dehne","year":"1999","unstructured":"Dehne KL, Grund JPC, Khodakevich L, Kobyshcha Y. The HIV\/AIDS epidemic among drug injectors in Eastern Europe: patterns, trends and determinants. J Drug Issues. 1999;29 Suppl 4:729\u201376.","journal-title":"J Drug Issues"},{"key":"105_CR6","doi-asserted-by":"crossref","unstructured":"Rhodes T, Ball A, Stimson GV, Kobyshcha Y, Fitch C, Pokrovsky V, et al. HIV infection associated with drug injecting in the Newly Independent States, Eastern Europe: the social and economic context of epidemics. Addiction. 1999;94(9):1323\u201336.","DOI":"10.1046\/j.1360-0443.1999.94913235.x"},{"issue":"Suppl. 9","key":"105_CR7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0277-9536(00)00104-0","volume":"51","author":"T Barnett","year":"2000","unstructured":"Barnett T, Whiteside A, Khodakevich L, Kruglov Y, Steshenko V. The HIV\/AIDS epidemic in Ukraine: its potential social and economic impact. Soc Sci Med. 2000;51 Suppl 9:1387\u2013403.","journal-title":"Soc Sci Med"},{"key":"105_CR8","doi-asserted-by":"crossref","unstructured":"Des Jarlais DC, Grund J-PC, Zadoretzky C, Milliken J, Friedmann P, Titus S, et al. HIV risk behaviour among participants of syringe exchange programmes in central\/eastern Europe and Russia. Int J Drug Policy. 2002;13:165\u201374.","DOI":"10.1016\/S0955-3959(02)00070-1"},{"key":"105_CR9","unstructured":"Balakireva OM, Grund J-PC, Barendregt C, Rubanets YV, Ryabova MV, Volyk AM, Levchuk N, Meshcherina O, Bondar T. Risk and protective factors in the initiation of injecting drug use: report of a respondent driven sampling study and strategy paper on preventing the initiation of injecting drug use among vulnerable adolescents and young people. Kiev: UNICEF\/UISR. [ http:\/\/www.unicef.org\/ukraine\/3_HIV_injecting_drug_users_en.pdf ]. Accessed 18 Mar 2013."},{"key":"105_CR10","doi-asserted-by":"crossref","unstructured":"Booth RE, Lehman WEK, Latkin CA, Dvoryak S, Brewster JT, Royer MS, et al. Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health. 2011;101 Suppl 2:336\u201343.","DOI":"10.2105\/AJPH.2009.172304"},{"key":"105_CR11","volume-title":"Possible epidemic spread of HIV by syringe-based drug sharing in Poland: paradigm for the new AIDS frontier: 28 June - 3 July 1998","author":"P Alcabes","year":"1998","unstructured":"Alcabes P, Grund JPC, Beniowski M, Bozek B, Kaciuba A, Zielinski A. Possible epidemic spread of HIV by syringe-based drug sharing in Poland: paradigm for the new AIDS frontier: 28 June - 3 July 1998. Geneva: 12th World AIDS Conference; 1998."},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1477-7517-8-32","volume":"8","author":"AB Latypov","year":"2011","unstructured":"Latypov AB. The Soviet doctor and the treatment of drug addiction: \u201ca difficult and most ungracious task\u201d. Harm Reduct J. 2011;8:32.","journal-title":"Harm Reduct J"},{"issue":"Suppl. 1","key":"105_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2005.11.027","volume":"83","author":"EJ Cone","year":"2006","unstructured":"Cone EJ. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet. Drug Alcohol Depend. 2006;83 Suppl 1:31\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl. 4","key":"105_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugpo.2013.04.007","volume":"24","author":"JPC Grund","year":"2013","unstructured":"Grund JPC, Latypov AB, Harris M. Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia. Int J Drug Policy. 2013;24 Suppl 4:265\u201374.","journal-title":"Int J Drug Policy"},{"issue":"Suppl. 7\u20138","key":"105_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/dta.1686","volume":"6","author":"SD Brandt","year":"2014","unstructured":"Brandt SD, King LA, Evans-Brown M. The new drug phenomenon. Drug Test Anal. 2014;6(Suppl 7\u20138):587\u201397.","journal-title":"Drug Test Anal"},{"issue":"Suppl. 7\u20138","key":"105_CR16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/dta.1622","volume":"6","author":"MC Hout Van","year":"2014","unstructured":"Van Hout MC. Kitchen chemistry: a scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions. Drug Test Anal. 2014;6(Suppl 7\u20138):778\u201387.","journal-title":"Drug Test Anal"},{"key":"105_CR17","doi-asserted-by":"crossref","DOI":"10.18356\/d30739c2-en","volume-title":"World drug report 2013","author":"UNODC","year":"2013","unstructured":"UNODC. World drug report 2013. Vienna: United Nations; 2013."},{"issue":"Suppl. 4","key":"105_CR18","first-page":"275","volume":"24","author":"L Azbel","year":"2013","unstructured":"Azbel L, Dvoryak S, Altice FL. \u2018Krokodil\u2019 and what a long strange trip it\u2019s been. Int J Drug Policy. 2013;24 Suppl 4:275\u201380.","journal-title":"Int J Drug Policy"},{"issue":"Suppl. 7","key":"105_CR19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/10826084.2012.669807","volume":"47","author":"M Gahr","year":"2012","unstructured":"Gahr M, Freudenmann RW, Hiemke C, Gunst IM, Connemann BJ, Schonfeldt-Lecuona C. \u201cKrokodil\u201d: revival of an old drug with new problems. Subst Use Misuse. 2012;47 Suppl 7:861\u20133.","journal-title":"Subst Use Misuse"},{"issue":"Suppl. 4","key":"105_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/10550887.2012.735570","volume":"31","author":"M Gahr","year":"2012","unstructured":"Gahr M, Freudenmann RW, Hiemke C, Gunst IM, Connemann BJ, Schonfeldt-Lecuona C. Desomorphine goes \u201ccrocodile\u201d. J Addict Dis. 2012;31 Suppl 4:407\u201312.","journal-title":"J Addict Dis"},{"issue":"Suppl. 3","key":"105_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjmed.2013.09.030","volume":"127","author":"DV Thekkemuriyi","year":"2014","unstructured":"Thekkemuriyi DV, John SG, Pilai U. \u201cKrokodil\u201d \u2014a designer drug from across the Atlantic, with serious consequences. Am J Med. 2014;127 Suppl 3:1\u20132.","journal-title":"Am J Med"},{"issue":"Suppl. 9","key":"105_CR22","volume":"16","author":"A Zheluk","year":"2014","unstructured":"Zheluk A, Quinn C, Meylakhs P. Internet search and krokodil in the Russian federation: an infoveillance study. J Med Internet Res. 2014;16 Suppl 9, e212.","journal-title":"J Med Internet Res"},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2015.02.001","volume":"249","author":"EA Alves","year":"2015","unstructured":"Alves EA, Grund JPC, Afonso CM, Netto AD, Carvalho F, Dinis-Oliveira RJ. The harmful chemistry behind krokodil (desomorphine) synthesis and mechanisms of toxicity. Forensic Sci Int. 2015;249:207\u201313.","journal-title":"Forensic Sci Int"},{"issue":"Suppl. 2","key":"105_CR24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.disamonth.2011.09.004","volume":"28","author":"D Vearrier","year":"2012","unstructured":"Vearrier D, Greenberg MI, Ney Miller S, Okaneku JT, Haggerty DA. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis Mon. 2012;28 Suppl 2:38\u201389.","journal-title":"Dis Mon"},{"issue":"Suppl. 11","key":"105_CR25","first-page":"79","volume":"166","author":"A Vernon","year":"2013","unstructured":"Vernon A. Response to \u201cone-pot\u201d meth labs. Fire Eng. 2013;166 Suppl 11:79\u201382.","journal-title":"Fire Eng"},{"key":"105_CR26","volume-title":"World drug report 2012","author":"UNODC","year":"2012","unstructured":"UNODC. World drug report 2012. Vienna: United Nations Publication; 2012."},{"issue":"Suppl. 1","key":"105_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Meth. 2005;8 Suppl 1:19\u201332.","journal-title":"Int J Soc Res Meth"},{"issue":"Suppl. 1","key":"105_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5 Suppl 1:69\u201378.","journal-title":"Implement Sci"},{"key":"105_CR29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2288-13-48","volume":"13","author":"HM Daudt","year":"2013","unstructured":"Daudt HM, van Mossel C, Scott S. Enhancing the scoping study methodology: a large, inter-professional team\u2019s experience with Arksey and O\u2019Malley\u2019s framework. BMC Med Res Methodol. 2013;13:48.","journal-title":"BMC Med Res Methodol"},{"key":"105_CR30","doi-asserted-by":"crossref","unstructured":"Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States 1988 through 1994. N Engl J Med. 1999;341 Suppl 8:556\u201362.","DOI":"10.1056\/NEJM199908193410802"},{"issue":"Suppl. 5","key":"105_CR31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"YI Hser","year":"2001","unstructured":"Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58 Suppl 5:503\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl. 6","key":"105_CR32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10865-004-0005-x","volume":"27","author":"YI Hser","year":"2004","unstructured":"Hser YI, Gelberg L, Hoffman V, Grella CE, McCarthy W, Anglin MD. Health conditions among aging narcotics addicts: medical examination results. J Behav Med. 2004;27 Suppl 6:607\u201322.","journal-title":"J Behav Med"},{"issue":"Suppl. 6","key":"105_CR33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0193841X07307315","volume":"31","author":"YI Hser","year":"2007","unstructured":"Hser YI, Huang D. Trajectories of heroin addiction: growth mixture modelling results based on a 33-year follow-up study. Evaluation Rev. 2007;31 Suppl 6:548\u201363.","journal-title":"Evaluation Rev"},{"key":"105_CR34","volume-title":"World drug report 2010","author":"UNODC","year":"2010","unstructured":"UNODC. World drug report 2010. Vienna: United Nations Publication; 2010."},{"issue":"Suppl. 4","key":"105_CR35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.94.07040715","volume":"7","author":"HA Hutchings","year":"1994","unstructured":"Hutchings HA, Eccles R. The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects. Eur Res J. 1994;7 Suppl 4:715\u20139.","journal-title":"Eur Res J"},{"issue":"Suppl. 1","key":"105_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2229-4708.81082","volume":"2","author":"M Bhandari","year":"2011","unstructured":"Bhandari M, Bhandari A, Bhandari A. Recent updates on codeine. Pharm Methods. 2011;2 Suppl 1:3\u20138.","journal-title":"Pharm Methods"},{"key":"105_CR37","doi-asserted-by":"crossref","unstructured":"Hou H, Yin S, Jia S, Hu S, Sun T, Chen Q, et al. Decreased striatal dopamine transporters in codeine-containing cough syrup abusers. Drug Alcohol Depend. 2011;118(Suppl 2\u20133):148\u201351.","DOI":"10.1016\/j.drugalcdep.2011.03.011"},{"issue":"Suppl. 6","key":"105_CR38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1742-1241.2000.tb11929.x","volume":"54","author":"TB Vree","year":"2000","unstructured":"Vree TB, van Dongen RT, Koopman-Kimenai PM. Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int J Clin Pract. 2000;54 Suppl 6:395\u20138.","journal-title":"Int J Clin Pract"},{"issue":"Suppl. 3","key":"105_CR39","first-page":"493","volume":"18","author":"DT Shek","year":"2006","unstructured":"Shek DT, Lam CM. Adolescent cough medicine abuse in Hong Kong: implications for the design of positive youth development programs in Hong Kong. Int J Adolesc Med Health. 2006;18 Suppl 3:493\u2013503.","journal-title":"Int J Adolesc Med Health"},{"key":"105_CR40","first-page":"143","volume":"14","author":"Y Yang","year":"2008","unstructured":"Yang Y, Yuan QY. Investigation and analysis on personalities of male-codeine phosphate addicts by MMPI. Chinese J Drug Abuse Prevent Treat. 2008;14:143\u20135.","journal-title":"Chinese J Drug Abuse Prevent Treat"},{"key":"105_CR41","unstructured":"Reed K, Bond A, Witton J, Cornish R, Hickman M, Strang J. The changing use of prescribed benzodiazepines and z-drugs and of over-the-counter codeine-containing products in England: a structured review of published english and international evidence and available data to inform consideration of the extent of dependence and harm. London: The National Addiction Centre, Kings College London; 2011"},{"issue":"Suppl. 1","key":"105_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugpo.2014.06.016","volume":"26","author":"MC Hout Van","year":"2015","unstructured":"Van Hout MC. Nod and wave: an Internet study of the codeine intoxication phenomenon. Int J Drug Policy. 2015;26 Suppl 1:67\u201377.","journal-title":"Int J Drug Policy"},{"key":"105_CR43","volume-title":"Disease control priorities related to mental, neurological, developmental and substance abuse disorders. Disease Control Priorities Project, Department of Mental Health and Substance Abuse","author":"World Health Organization (WHO)","year":"2006","unstructured":"World Health Organization (WHO). Disease control priorities related to mental, neurological, developmental and substance abuse disorders. Disease Control Priorities Project, Department of Mental Health and Substance Abuse. Geneva: WHO; 2006."},{"issue":"Suppl. 4","key":"105_CR44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.drugpo.2008.09.003","volume":"20","author":"R Chintalova-Dallas","year":"2009","unstructured":"Chintalova-Dallas R, Case P, Kitsenko N, Lazzarine Z. Boltushka: homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine. Int J Drug Policy. 2009;20 Suppl 4:347\u201351.","journal-title":"Int J Drug Policy"},{"issue":"135","key":"105_CR45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2013.11.018","volume":"2014","author":"S Mackey","year":"2014","unstructured":"Mackey S, Stewart JL, Connolly CG, Tapert SF, Paulus MP. A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine. Drug Alcohol Depend. 2014;2014(135):104\u201311.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"105_CR46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/mp.2008.90","volume":"14","author":"SM Berman","year":"2009","unstructured":"Berman SM, Kuczenski R, McCracken JT, London ED. Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry. 2009;14(2):123\u201342.","journal-title":"Mol Psychiatry"},{"key":"105_CR47","volume-title":"Results from the 2010 national survey on drug use and health: summary of national findings","author":"Substance Abuse and Mental Health Services Administration","year":"2011","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2010 national survey on drug use and health: summary of national findings. Rockville, MD: NSDUH Series H-41; 2011."},{"key":"105_CR48","doi-asserted-by":"crossref","unstructured":"Tait RJ, McKetin R, Kay-Lambkin F, Bennett K, Tam A, Bennett A, et al. Breakingtheice: a protocol for a randomised controlled trial of an internet-based intervention addressing amphetamine-type stimulant use. BMC Psychiatry. 2012;12:67\u201375.","DOI":"10.1186\/1471-244X-12-67"},{"key":"105_CR49","doi-asserted-by":"crossref","unstructured":"Colofax G, Santos GM, Chu P, Vittinghoff E, Pluddemann A, Kumar S, et al. Amphetamine-group substances and HIV. Lancet. 2010;376(9739):458\u201374.","DOI":"10.1016\/S0140-6736(10)60753-2"},{"key":"105_CR50","volume-title":"Patterns and trends of amphetamine-type stimulants and other drugs: challenges for Asia and the Pacific","author":"UNODC","year":"2010","unstructured":"UNODC. Patterns and trends of amphetamine-type stimulants and other drugs: challenges for Asia and the Pacific. Vienna: UNODC; 2010."},{"issue":"Suppl. 3","key":"105_CR51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/09595230801932588","volume":"27","author":"P Griffiths","year":"2008","unstructured":"Griffiths P, Mravcik V, Lopez D, Klempova D. Quite a lot of smoke but very limited fire\u2014the use of methamphetamine in Europe. Drug Alcohol Rev. 2008;27 Suppl 3:236\u201342.","journal-title":"Drug Alcohol Rev"},{"issue":"Suppl. 4","key":"105_CR52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2013.05.009","volume":"24","author":"RE Booth","year":"2013","unstructured":"Booth RE. \u2018Krokodil\u2019 and other home-produced drugs for injection: a perspective from Ukraine. Int J Drug Policy. 2013;24 Suppl 4:277\u20138.","journal-title":"Int J Drug Policy"},{"key":"105_CR53","volume-title":"Injecting illicit drugs. Volume 8","author":"JP Grund","year":"2006","unstructured":"Grund JP. The eye of the needle: an ethno erpidemiological analysis of injecting drug use. In: Pates R, McBride A, Arnold K, editors. Injecting illicit drugs. Volume 8. 1st ed. London: Blackwell; 2006.","edition":"1"},{"issue":"Suppl. 1","key":"105_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/002204260703700108","volume":"37","author":"T Z\u00e1bransk\u00fd","year":"2007","unstructured":"Z\u00e1bransk\u00fd T. Methamphetamine in the Czech Republic. J Drug Issues. 2007;37 Suppl 1:155\u201380.","journal-title":"J Drug Issues"},{"key":"105_CR55","volume-title":"Perspectives on drugs. Health and social responses for methamphetamine users","author":"EMCDDA","year":"2014","unstructured":"EMCDDA. Perspectives on drugs. Health and social responses for methamphetamine users. EMCDDA: Lisbon; 2014."},{"key":"105_CR56","unstructured":"Walker S. Krokodil: the drug that eats junkies. The Independent. [ http:\/\/www.independent.co.uk\/news\/world\/europe\/krokodil-the-drug-that-eats-junkies-2300787.html ]. Accessed 4 Jan 2013."},{"key":"105_CR57","unstructured":"Shuster S. The curse of the crocodile: Russia\u2019s deadly designer drug. Time Magazine. [ http:\/\/content.time.com\/time\/world\/article\/0,8599,2078355,00.html ]. Accessed 4 Jan 2013."},{"issue":"Suppl. 4","key":"105_CR58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/15563650.2012.660574","volume":"50","author":"R Skowronek","year":"2012","unstructured":"Skowronek R, Celi\u0144ski R, Chowaniec C. \u201cCrocodile\u201d\u2014new dangerous designer drug of abuse from the East. Clin Toxicol (Phil). 2012;50 Suppl 4:269.","journal-title":"Clin Toxicol (Phil)"},{"key":"105_CR59","volume-title":"Methamphetamine and amphetamines","author":"D Aretha","year":"2005","unstructured":"Aretha D. Methamphetamine and amphetamines. Ernslow: Berkeley Heights, NJ; 2005."},{"issue":"Suppl. 1","key":"105_CR60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7517-2-16","volume":"2","author":"K Barcal","year":"2005","unstructured":"Barcal K, Schumacher JE, Dumchev K, Moroz LV. A situational picture of HIV\/AIDS and injection drug use in Vinnitsya, Ukraine. Harm Reduct J. 2005;2 Suppl 1:16.","journal-title":"Harm Reduct J"},{"issue":"Suppl. 2","key":"105_CR61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/15563650802010388","volume":"47","author":"F Varlibas","year":"2009","unstructured":"Varlibas F, Delipoyraz I, Yuksel G, Filiz G, Tireli H, Gecim NO. Neurotoxicity following chronic intravenous use of \u201cRussian cocktail\u201d. Clin Toxicol (Phil). 2009;47 Suppl 2:157\u201360.","journal-title":"Clin Toxicol (Phil)"},{"key":"105_CR62","unstructured":"Lindblad KE. Bad news: people are taking krokodil in Norway. [ http:\/\/www.vice.com\/en_uk\/read\/krokodil-norway ]. Accessed 19 Nov 2013."},{"issue":"Suppl. 2","key":"105_CR63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lfs.2014.03.008","volume":"102","author":"M Katselou","year":"2014","unstructured":"Katselou M, Papoutsis I, Nikolaou P, Spiliopoulou C, Athanaselis S. A \u201cKrokodil\u201d emerges from the murky waters of addiction. Abuse trends of an old drug. Life Sci. 2014;102 Suppl 2:81\u20137.","journal-title":"Life Sci"},{"key":"105_CR64","first-page":"8","volume":"214","author":"G Piralishvili","year":"2013","unstructured":"Piralishvili G, Gamkrelidze I, Nikolaishvili N, Chavchanidze M. Needs assessment and treatment compliance at state opioid substitution treatment programmes in Georgia. Georgian Med News. 2013;214:8\u201332.","journal-title":"Georgian Med News"},{"issue":"Suppl. 4","key":"105_CR65","first-page":"281","volume":"24","author":"M Harris","year":"2012","unstructured":"Harris M. The \u2018do-it-yourself\u2019 New Zealand injecting scene: implications for harm reduction. Int J Drug Policy. 2012;24 Suppl 4:281\u20133.","journal-title":"Int J Drug Policy"},{"key":"105_CR66","unstructured":"Der Spiegel. Todesdroge Krokodil erreicht Deutschland. [Death drugs crocodile reaches Germany]. [ http:\/\/www.spiegel.de\/panorama\/justiz\/russischerheroinersatz-todesdroge-krokodil-erreicht-deutschland-a-791273.html ]. Accessed 18 Nov 2013."},{"key":"105_CR67","unstructured":"Rowlands J, Kyriakos K. Sisa: is meth use the latest face of the catastrophe in Athens? [ http:\/\/www.opendemocracy.net\/can-europe-make-it\/joseph-rowlands-kyriakos-klosidis\/sisa-is-meth-use-latest-face-of-catastrophe-in -]. Accessed 27 Mar 2014."},{"key":"105_CR68","unstructured":"Miller A. Austerity\u2019s drug of choice. Sisa is destroying the lives of Athens\u2019s homeless people. [ http:\/\/www.vice.com\/en_uk\/read\/austeritys-drug-of-choice-000757-v20n5 ]. Accessed 19 Nov 2013."},{"key":"105_CR69","volume-title":"Kerncijfers Verslavingszorg 2013. Landelijk Alcohol en Drugs Informatie Systeem (LADIS)","author":"DJ Wisselink","year":"2014","unstructured":"Wisselink DJ, Kuijpers WGT, Mol A. Kerncijfers Verslavingszorg 2013. Landelijk Alcohol en Drugs Informatie Systeem (LADIS). Houten: Stichting IVZ; 2014."},{"key":"105_CR70","volume-title":"GHB overdose prevention among people who use GHB at home in the Netherlands and Belgium (2014-2015)","author":"S Gaalen van","year":"2015","unstructured":"van Gaalen S, de Bruin D, Grund J-PC. GHB overdose prevention among people who use GHB at home in the Netherlands and Belgium (2014-2015). An exploration of the characteristics associated with overdose and opportunities for risk reduction. Amsterdam: Mainline Foundation; 2015."},{"issue":"Suppl. 4","key":"105_CR71","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s10461-008-9359-3","volume":"12","author":"RE Booth","year":"2008","unstructured":"Booth RE, Lehman W, Kwiatkowski C, Brewster J, Sinitsyna L, Dvoryak S. Stimulant injectors in Ukraine: the next wave of the epidemic? AIDS Behav. 2008;12 Suppl 4:652\u201361.","journal-title":"AIDS Behav"},{"key":"105_CR72","doi-asserted-by":"crossref","unstructured":"Platt L, Rhodes T, Hickman M, Mikhailova L, Lisetsky K, Sarang A, et al. Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. J Acquir Immune Defic Syndr. 2008;47 Suppl 5:623\u201331.","DOI":"10.1097\/QAI.0b013e318165dbf7"},{"key":"105_CR73","first-page":"301","volume-title":"Harm reduction in substance use and high-risk behaviour: international policy and practice summaries. Volume 32","author":"T Zabransky","year":"2012","unstructured":"Zabransky T, Grund JPC, Latypov A, Otiashvili D, Stuikyte R, Scutelniciuc O. (2012) Harm reduction in central and Eastern Europe. In: Pates R, Riley D, editors. Harm reduction in substance use and high-risk behaviour: international policy and practice summaries. Volume 32. 5th ed. Oxford: Wiley Blackwell; 2012. p. 301\u201321.","edition":"5"},{"key":"105_CR74","volume-title":"Trends in the abuse of prescription drugs","author":"J Carlisle Maxwell","year":"2006","unstructured":"Carlisle Maxwell J. Trends in the abuse of prescription drugs. Austin, Texas: The Gulf Coast Addiction Technology Transfer Center (GCATTC); 2006."},{"issue":"1","key":"105_CR75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2011.05.014","volume":"23","author":"SE Lankenau","year":"2012","unstructured":"Lankenau SE, Teti M, Silva K, Jackson Bloom J, Harocopos A, Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy. 2012;23(1):37\u201344.","journal-title":"Int J Drug Policy"},{"issue":"Suppl. 4","key":"105_CR76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00952990.2011.569623","volume":"37","author":"N Katz","year":"2011","unstructured":"Katz N, Dart RC, Bailey E, Trudeau J, Osgood E, Paillard F. Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse. 2011;37 Suppl 4:205\u201317.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"105_CR77","volume-title":"The non-medicinal use of prescription drugs. Policy direction issues. Discussion paper","author":"UNODC","year":"2011","unstructured":"UNODC. The non-medicinal use of prescription drugs. Policy direction issues. Discussion paper. Vienna: UNODC; 2011."},{"issue":"Suppl. 9","key":"105_CR78","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1081\/JA-120018480","volume":"38","author":"GF Fleming","year":"2003","unstructured":"Fleming GF, McElnay JC, Hughes CM. The separation of codeine from nonprescription combination analgesic products. Subst Use Misuse. 2003;38 Suppl 9:1217\u201326.","journal-title":"Subst Use Misuse"},{"issue":"Suppl. 3","key":"105_CR79","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jsat.2005.08.013","volume":"30","author":"SM Gordon","year":"2006","unstructured":"Gordon SM, Forman RF, Siatkowski C. Knowledge and use of the internet as a source of controlled substances. J Subst Abuse Treat. 2006;30 Suppl 3:271\u20134.","journal-title":"J Subst Abuse Treat"},{"issue":"Suppl. 8","key":"105_CR80","first-page":"1","volume":"6","author":"SH Budman","year":"2009","unstructured":"Budman SH, Grimes Serrano JM, Butler SF. Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct J. 2009;6 Suppl 8:1\u20137.","journal-title":"Harm Reduct J"},{"issue":"Suppl. 1","key":"105_CR81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1465-3362.2008.00004.x","volume":"28","author":"S Nielsen","year":"2009","unstructured":"Nielsen S, Barratt MJ. Prescription drug misuse: is technology friend or foe? Drug Alcohol Rev. 2009;28 Suppl 1:81\u20136.","journal-title":"Drug Alcohol Rev"},{"issue":"Suppl. 13","key":"105_CR82","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2165\/11537940-000000000-00000","volume":"70","author":"RB Raffa","year":"2010","unstructured":"Raffa RB, Pergolizzi JV. Opioid formulations designed to resist\/deter abuse. Drugs. 2010;70 Suppl 13:1657\u201375.","journal-title":"Drugs"},{"key":"105_CR83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2012.12.028","volume":"130","author":"MK Romach","year":"2013","unstructured":"Romach MK, Schoedel KA, Sellers EM. Update on tamper resistant drug formulations. Drug Alcohol Depend. 2013;130:13.","journal-title":"Drug Alcohol Depend"},{"key":"105_CR84","volume-title":"The Internet and drug markets","author":"EMCDDA","year":"2015","unstructured":"EMCDDA. The Internet and drug markets. 2015. Summary of results from an EMCDDA Trendspotter study. LisbonL EMCDDA."},{"key":"105_CR85","doi-asserted-by":"crossref","unstructured":"Dolliver DS. Evaluating drug trafficking on the Tor Network: Silk Road 2, the sequel. Int J Drug Policy. 2015;26:1113-23. Available online 14 Jan 2015.","DOI":"10.1016\/j.drugpo.2015.01.008"},{"key":"105_CR86","unstructured":"Konrad A. Feds say they\u2019ve arrested \u2018dread pirate Roberts,\u2019 shut down his black market \u2018the Silk Road\u2019. [ http:\/\/www.forbes.com\/sites\/alexkonrad\/2013\/10\/02\/feds-shut-down-silk-road-owner-known-as-dread-pirate-roberts-arrested ]. Accessed 18 Mar 2015."},{"issue":"Suppl. 5","key":"105_CR87","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/add.12470","volume":"109","author":"MJ Barratt","year":"2014","unstructured":"Barratt MJ, Ferris JA, Winstock AR. Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction. 2014;109 Suppl 5:774\u201383.","journal-title":"Addiction"},{"issue":"Suppl. 4","key":"105_CR88","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/09638237.2012.682265","volume":"21","author":"Z Davey","year":"2012","unstructured":"Davey Z, Schifano F, Corazza O, Deluca P. e-Psychonauts: conducting research in online drug forum communities. J Ment Health. 2012;21 Suppl 4:386\u201394.","journal-title":"J Ment Health"},{"issue":"Suppl. 3","key":"105_CR89","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugpo.2011.12.003","volume":"23","author":"AJM Forsyth","year":"2012","unstructured":"Forsyth AJM. Virtually a drug scare: mephedrone and the impact of the Internet on drug news transmission. Int J Drug Policy. 2012;23 Suppl 3:198\u2013209.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"105_CR90","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.drugpo.2013.08.011","volume":"24","author":"MC Hout Van","year":"2013","unstructured":"Van Hout MC, Bingham T. \u2018Surfing the Silk Road\u2019: a study of users\u2019 experiences. Int J Drug Policy. 2013;24(6):524\u20139.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"105_CR91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2013.10.009","volume":"25","author":"MC Hout Van","year":"2014","unstructured":"Van Hout MC, Bingham T. Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. Int J Drug Policy. 2014;25(2):183\u20139.","journal-title":"Int J Drug Policy"},{"issue":"Suppl. 8","key":"105_CR92","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3109\/10826084.2013.800117","volume":"48","author":"E Chiauzzi","year":"2013","unstructured":"Chiauzzi E, DasMahapatra P, Lobo K, Barratt MJ. Participatory research with an online drug forum: a survey of user characteristics, information sharing, and harm reduction views. Subst Use Misuse. 2013;48 Suppl 8:661\u201370.","journal-title":"Subst Use Misuse"},{"key":"105_CR93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7517-10-18","volume":"10","author":"L M\u00f3r\u00f3","year":"2013","unstructured":"M\u00f3r\u00f3 L, R\u00e1cz J. Online drug user-led harm reduction in Hungary: a review of \u201cDaath\u201d. Harm Reduct J. 2013;10:18.","journal-title":"Harm Reduct J"},{"key":"105_CR94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7517-11-25","volume":"11","author":"C Soussan","year":"2014","unstructured":"Soussan C, Kjellgren A. Harm reduction and knowledge exchange\u2014a qualitative analysis of drug-related internet discussion forums. Harm Reduct J. 2014;11:25.","journal-title":"Harm Reduct J"},{"key":"105_CR95","first-page":"9","volume":"9","author":"C Soussan","year":"2015","unstructured":"Soussan C, Kjellgren A. \u201cChasing the high\u201d\u2014experiences of ethylphenidate as described on international Internet forums. Subst Abuse. 2015;9:9\u201316.","journal-title":"Subst Abuse"},{"issue":"Suppl. 1","key":"105_CR96","first-page":"30","volume":"47","author":"MC Hout Van","year":"2014","unstructured":"Van Hout MC, Hearne E. \u2018Word of mouse\u2019: indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine. J Psychoact Drugs. 2014;47 Suppl 1:30\u201341.","journal-title":"J Psychoact Drugs"},{"key":"105_CR97","unstructured":"EHRN. Young people and injecting drug use in selected countries of Central and Eastern Europe. [ http:\/\/www.harm-reduction.org\/library\/young-people-injecting-drug-use-selected-countries-central-andeastern-europe ]. Accessed 9 Nov 2013."},{"key":"105_CR98","doi-asserted-by":"crossref","unstructured":"Clatts MC, Heimer R, Abdala N, Goldsamt L, Sotheran J, Anderson KT, et al. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1. J Acquir Immune Defic Syndr. 1999;22(2):194\u20139.","DOI":"10.1097\/00126334-199910010-00013"},{"key":"105_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.1991.10472569","volume":"23","author":"JPC Grund","year":"1991","unstructured":"Grund JPC, Kaplan CD, Adriaans NFP, Blanken P. Drug sharing and HIV transmission risks: the practice of \u201cfrontloading\u201d in the Dutch injecting drug user population. J Psychoact Drugs. 1991;23:1\u201310.","journal-title":"J Psychoact Drugs"},{"key":"105_CR100","doi-asserted-by":"crossref","unstructured":"Dumchev KV, Soldyshev R, Qian HZ, Zezyulin OO, Chandler SD, Slobodyanyuk P, et al. HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey. Harm Reduction Journal. 2009;6:23.","DOI":"10.1186\/1477-7517-6-23"},{"issue":"1","key":"105_CR101","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","volume":"91","author":"H Hagan","year":"2001","unstructured":"Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91(1):42\u20136.","journal-title":"Am J Public Health"},{"key":"105_CR102","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/313703","volume":"30","author":"IA Binswanger","year":"2000","unstructured":"Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579\u201381.","journal-title":"Clin Infect Dis"},{"key":"105_CR103","doi-asserted-by":"crossref","unstructured":"Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33:35\u201340.","DOI":"10.1086\/320879"},{"key":"105_CR104","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1081\/JA-120025125","volume":"38","author":"D Ciccarone","year":"2003","unstructured":"Ciccarone D, Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse. 2003;38:2049\u201363.","journal-title":"Subst Use Misuse"},{"key":"105_CR105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2458-8-405","volume":"8","author":"E Lloyd-Smith","year":"2008","unstructured":"Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Pub Health. 2008;8:405.","journal-title":"BMC Pub Health"},{"key":"105_CR106","volume-title":"The GAP report 2014: people who inject drugs","author":"UNAIDS","year":"2014","unstructured":"UNAIDS. The GAP report 2014: people who inject drugs. Geneva: UNAIDS; 2014."},{"key":"105_CR107","unstructured":"Asaeva AV, Ocheret D, Fayziev Zh. Russia: New trends in drug use lead to severe health consequences and death among IDUs: 3-7 April 2011; 22nd international conference on the reduction of drug related harm, Beirut, 2011."},{"key":"105_CR108","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jcms.2014.05.005","volume":"42","author":"YM Poghosyan","year":"2014","unstructured":"Poghosyan YM, Hakobyan KA, Poghosyan AY, Avetisyan EK. Surgical treatment of jaw osteonecrosis in \u201cKrokodil\u201d drug addicted patients. J Cranio-Maxillo- Fac Surg. 2014;42:1639\u201343.","journal-title":"J Cranio-Maxillo- Fac Surg"},{"key":"105_CR109","unstructured":"Orekhovsky V, Calzavara L, Yakovlev A, Nikitina T, Volkova G, Michalchenko M, Saldanha V. Fuelling HIV epidemic in Russia: the stigma of IDU and HIV and its impact on treatment access and testing. In: Poster presentation, The XIV international AIDS conference: 7-12 July, 2002; Barcelona: Spain; 2002."},{"key":"105_CR110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7517-5-23","volume":"5","author":"R Elovich","year":"2008","unstructured":"Elovich R, Drucker E. On drug treatment and social control: Russian narcology\u2019s great leap backwards. Harm Reduct J. 2008;5:23.","journal-title":"Harm Reduct J"},{"issue":"Suppl. 9738","key":"105_CR111","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","volume":"376","author":"D Wolfe","year":"2010","unstructured":"Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376 Suppl 9738:355\u201366.","journal-title":"Lancet"},{"key":"105_CR112","first-page":"223","volume":"3","author":"J Couper","year":"1873","unstructured":"Couper J. Sur les effets du peroxide de mangan\u00e8se. Journal de chimie m\u00e9dicale, de pharmacie et de toxicologie. 1873;3:223\u20135.","journal-title":"Journal de chimie m\u00e9dicale, de pharmacie et de toxicologie"},{"key":"105_CR113","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/nbm.931","volume":"17","author":"J Crossgrove","year":"2004","unstructured":"Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed. 2004;17:544\u201353.","journal-title":"NMR Biomed"},{"issue":"4","key":"105_CR114","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12017-009-8108-8","volume":"11","author":"RG Lucchini","year":"2009","unstructured":"Lucchini RG, Martin CJ, Doney BC. From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure. Neuromolecular Med. 2009;11(4):311\u201321. Jan [cited 2015 Apr 1]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20012385 .","journal-title":"Neuromolecular Med"},{"key":"105_CR115","doi-asserted-by":"crossref","unstructured":"Sikk K, Haldre S, Aquilonius SM, Taba P. Manganese-induced parkinsonism due to ephedrone abuse. Parkinsons Dis. 2011;4:1-8.","DOI":"10.4061\/2011\/865319"},{"issue":"6","key":"105_CR116","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archneur.64.6.886","volume":"64","author":"RMA Bie de","year":"2007","unstructured":"de Bie RMA, Gladstone RM, Strafella AP, Ko JH, Lang AE. Manganese-induced parkinsonism associated with methcathinone (ephedrone) abuse. Arch Neurol. 2007;64(6):886\u20139.","journal-title":"Arch Neurol"},{"issue":"Suppl. 2","key":"105_CR117","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5271\/sjweh.1369","volume":"21","author":"R Lucchini","year":"1995","unstructured":"Lucchini R, Selis L, Folli D, Apostoli P, Mutti A, Vanoni O, et al. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health. 1995;21 Suppl 2:143\u20139.","journal-title":"Scand J Work Environ Health"},{"issue":"Suppl. 1","key":"105_CR118","first-page":"27","volume":"1","author":"D Papanti","year":"2014","unstructured":"Papanti D, Grund J-P, Francesconi F, Orsolini L, Schifano F. (New) Glocal syndremics: the \u2018M-cat\u2019 tale. Res Advances Psychiatry. 2014;1 Suppl 1:27.","journal-title":"Res Advances Psychiatry"},{"key":"105_CR119","unstructured":"Bluelight. Manganese poisoning from ephedrone (MCAT). [ http:\/\/bluelight.org\/vb\/archive\/index.php\/t-665468.html ]. Accessed 6 Apr 2014."},{"key":"105_CR120","first-page":"207","volume-title":"Health behavior and health education: theory, research and practice","author":"BF Oldenburg","year":"1997","unstructured":"Oldenburg BF, Hardcastle DM, Kok G. Diffusion of innovations. In: Glanz K, Lewis FM, Rimer B, editors. Health behavior and health education: theory, research and practice. 2nd ed. San Francisco: Jossey-Bass; 1997. p. 207\u201386.","edition":"2"},{"issue":"Suppl. 1","key":"105_CR121","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1360-0443.2001.96116512.x","volume":"96","author":"R Ferrence","year":"2001","unstructured":"Ferrence R. Diffusion theory and drug use. Addiction. 2001;96 Suppl 1:165\u201373.","journal-title":"Addiction"},{"key":"105_CR122","doi-asserted-by":"crossref","unstructured":"Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014.","DOI":"10.1016\/S0140-6736(10)60232-2"},{"key":"105_CR123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7517-5-24","volume":"5","author":"R Pizzey","year":"2008","unstructured":"Pizzey R, Hunt N. Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation. Harm Reduct J. 2008;5:24.","journal-title":"Harm Reduct J"},{"issue":"10","key":"105_CR124","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/add.12243","volume":"108","author":"MJ Bojko","year":"2013","unstructured":"Bojko MJ, Dvoriak S, Altice FL. At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine. Addiction. 2013;108(10):1697\u20139.","journal-title":"Addiction"},{"key":"105_CR125","volume-title":"Harm reduction: evidence, impacts and challenges","author":"D Hedrich","year":"2010","unstructured":"Hedrich D, Kerr T, Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T, Hendrich D, editors. Harm reduction: evidence, impacts and challenges. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Scientific Monograph, Office of the European Union; 2010."},{"key":"105_CR126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000423","volume":"8","author":"SS Alistar","year":"2011","unstructured":"Alistar SS, Owens DK, Brandeau ML. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med. 2011;8, e1000423.","journal-title":"PLoS Med"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-016-0105-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T18:08:58Z","timestamp":1692295738000},"score":1,"resource":{"primary":{"URL":"http:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-016-0105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1186\/s12954-016-0105-2","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]},"article-number":"14"}}